20 mg/ml to 300 mg/ml CBD
CBD oils can be developed in strengths such as 20 mg/ml, 50 mg/ml, 100 mg/ml, 150 mg/ml, 200 mg/ml, and 300 mg/ml CBD, depending on customer requirements, formulation feasibility, and market specifications.
Medical cannabis oil contract manufacturing
Pharmaceutical Medical Cannabis Oils & Tinctures
Contract manufactured under GMP principles for the international medical cannabis sector.
Pharmaceutical medical cannabis oils
Cilo Cybin offers contract manufacturing services for pharmaceutical-grade medical cannabis oils and tinctures.
Cilo Cybin offers contract manufacturing services for pharmaceutical-grade medical cannabis oils and tinctures, supporting licensed partners across the international medical cannabis sector with high-quality, consistent, and commercially ready oral-liquid formulations.
Our oil and tincture manufacturing pathway is built around Good Manufacturing Practice principles, with processes designed to align with the expectations of regulated pharmaceutical supply chains. By applying PIC/S GMP guideline principles across formulation, production, documentation, quality control, and release planning, we help our customers develop medical cannabis oil products that are reliable, repeatable, and suitable for demanding global markets.
For partners looking to bring a new cannabinoid oil to market, refine an existing formulation, or scale a product for commercial supply, Cilo Cybin provides a controlled contract manufacturing platform supported by cannabinoid expertise, formulation development, packaging capability, and quality-focused production systems.
In-process oil manufacturing
From formulation bench work to measured oral-liquid presentation.
Oil programs move through controlled formulation, measured filling, container-closure review, and finished-product presentation so cannabinoid potency, appearance, viscosity, and dosing format remain aligned from development through commercial supply.
GMP-led oil formulation and contract manufacturing
Medical cannabis oils require more than simply combining cannabinoids with a carrier oil.
Each product must be developed with attention to potency, cannabinoid stability, dose consistency, excipient compatibility, appearance, viscosity, flavour profile, packaging format, and the requirements of the intended destination market.
Cilo Cybin supports customers through a structured development process, from initial product concept through formulation, bench trials, scale-up, filling, packaging, stability planning, and batch documentation. Our approach is guided by pharmaceutical manufacturing discipline, helping partners produce oils and tinctures with the consistency expected in regulated medical cannabis supply.
Our contract manufacturing service can support a wide range of oil-based cannabinoid products, including CBD-dominant oils, THC-dominant oils, balanced CBD:THC oils, minor cannabinoid formulations, terpene-enhanced formulations, and nano-emulsion or nano-enabled cannabinoid delivery formats where appropriate.
Formulation services for major and minor cannabinoids
We work with a broad range of cannabinoid inputs to help customers develop differentiated oil products.
Formulation support can include major cannabinoids such as THC, CBD, CBN, and CBG, as well as minor cannabinoids including THCV, CBC, CBDV, and other emerging cannabinoid ingredients.
Ratio and potencyCannabinoid ratio development and target potency selection
Carrier and sensory profileCarrier oil selection, terpene integration, flavour profile, and sensory considerations
Packaging compatibilityCompatibility with selected bottle, dropper, pipette, syringe, or closure systems
Advanced formatsNano-emulsion and nano-enabled oil technologies where appropriate
Example oil formulation profiles
Cilo Cybin can manufacture cannabinoid oils and tinctures across standard and bespoke potency profiles.
Defined dual-cannabinoid profiles
Balanced medical cannabis oils can be produced in ratios such as 10:10 mg/ml CBD:THC, 15:15 mg/ml CBD:THC, 25:25 mg/ml CBD:THC, and 50:50 mg/ml CBD:THC.
20 mg/ml to 300 mg/ml THC
THC-dominant oil formulations can be developed in strengths such as 20 mg/ml, 50 mg/ml, 100 mg/ml, 150 mg/ml, 200 mg/ml, and 300 mg/ml THC, subject to licensed market requirements and applicable regulatory controls.
Minor cannabinoids, terpenes, and bespoke combinations
Custom formulations can also be developed using CBN, CBG, THCV, CBC, CBDV, terpene blends, and other cannabinoid combinations where technically and commercially appropriate.
Stability protocol development and stability studies
Stability is a critical part of pharmaceutical medical cannabis oil development and market readiness.
Cilo Cybin can assist customers with stability protocol development and, where required, structured stability studies to help evaluate product performance over time.
Stability work may include assessment of cannabinoid potency, degradation profile, appearance, clarity, viscosity, container-closure compatibility, terpene behaviour, and other relevant product attributes. This supports customers in building a stronger technical data package for their oil or tincture product and helps inform shelf-life planning, packaging decisions, and market-specific documentation.
Packaging and finished-product presentation
We support a variety of bottle sizes, closure systems, and measured-dosing formats.
This includes dropper bottles, graduated pipettes, syringes, tamper-evident closures, and other controlled oral-liquid packaging configurations.
Packaging scopeBulk oil, filled bottles, or finished packaged product
Dosing formatsDroppers, graduated pipettes, syringes, and measured oral-liquid systems
Commercial fitCustomer brand, dosage format, and destination-market expectations
Documentation needsBatch documentation, packaging controls, and release-planning support
A quality-focused partner for global cannabis oil programs
Cilo Cybin supports partners looking for more than basic production capacity.
Cilo Cybin's contract manufacturing service is designed for licensed cannabis companies, pharmaceutical partners, and medical cannabis brands that require more than basic production capacity. We support partners looking for a manufacturer that understands cannabinoid formulation, GMP-led controls, international supply expectations, and the importance of repeatable quality.
By combining cannabinoid formulation expertise with Good Manufacturing Practice principles, PIC/S GMP-aligned thinking, and a pharmaceutical approach to production, Cilo Cybin helps customers develop high-quality medical cannabis oils and tinctures for regulated markets.
Other contract manufacturing routes
Explore the other finished-product pathways supported under the same GMP manufacturing platform.
Use these routes to move between adjacent contract-manufacturing formats without leaving the finished-products section.
Partner enquiry
Develop your next medical cannabis oil with Cilo Cybin.
Speak to our team about your target cannabinoid profile, required potency, formulation objectives, packaging format, stability requirements, and intended market. Cilo Cybin can help scope a contract manufacturing pathway for CBD oils, THC oils, balanced CBD:THC oils, minor cannabinoid formulations, terpene-enhanced oils, and nano-enabled medical cannabis oil products.